federal_register: E9-9901

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
E9-9901 Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin Rule The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA revises the minimum age of treatment from 6 weeks to 8 weeks for kittens treated with a topical selamectin solution. 2009-04-30 2009 4 https://www.federalregister.gov/documents/2009/04/30/E9-9901/ophthalmic-and-topical-dosage-form-new-animal-drugs-selamectin https://www.govinfo.gov/content/pkg/FR-2009-04-30/pdf/E9-9901.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA revises the minimum age of treatment from 6 weeks to 8...

Links from other tables